The Food and Drug Administration (FDA), the agency responsible for the regulation of health products in the United States, authorized this Friday (29) the application of the vaccine against Covid-19 of the Pfizer/BioNTech partnership in children between five and 11 years old. age. It was the first immunization against the new coronavirus authorized for Americans in this age group.
In a statement, the FDA noted that the safety of the vaccine was analyzed in approximately 3,100 children aged five to 11 years who received the immunizing agent and no serious side effects were detected in the study, which is still ongoing.
The analyzes showed that the immune responses of children in this age group were comparable to those of people aged 16 to 25 years old. In addition, the vaccine was found to be 90.7% effective in preventing Covid-19 in children aged five to 11 years.
The FDA said the US Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices will meet next week to discuss other clinical recommendations.
#approves #application #Pfizer #vaccine #children #aged #years